Ask your competent? doctor if this has proven better than all these previous exoskeletons! NO knowledge of them; FIRE THAT IDIOT!
No excuses are allowed, your doctor is supposed to know this stuff, and because s/he doesn't YOU get to be the failure point of not recovering. My doctor knew nothing of stroke rehab as completely proven by writing three prescriptions to PT, OT, ST all saying the same thing(E.T- Evaluate and Treat) completely proving NO knowledge of anthing that will hep you recover! I could train a chimpanzee to write that.
Ask your doctor which of these walking exoskeletons will get you 100% recovered, meaning walking without the exoskeleton.
There are many more exoskeletons out there. Which ones has your hospital tested?
Maybe these?
5-Link model based gait trajectory adaption control strategies of the gait rehabilitation exoskeleton for post-stroke patients August 2020
A Control Framework of Lower Extremity Rehabilitation Exoskeleton based on Neuro-Muscular-Skeletal Model.pdf August 2020
Passive-elastic knee-ankle exoskeleton reduces the metabolic cost of walking July 2020
Effects of a wearable exoskeleton stride management assist system (SMA®) on spatiotemporal gait characteristics in individuals after stroke: a randomized controlled trial June 2020
The H2 robotic exoskeleton for gait rehabilitation after stroke: early findings from a clinical study May 2020
Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility April 2020
Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility January 2020
I gave up listing them all, it is your doctor's job to know this.
Your doctor can analyze the intersection of these multiple sets of data.
No knowledge of ALL OF THESE IS COMPLETE FUCKING INCOMPETENCE!
LOPES was first written up in Sept. 2007.
LOPES researchers hope to get the device into rehabilitation clinics by early 2012, with a mid-2012 target for introduction into the market. Is it available and does your hospital know about it? Have they been following this for the past 13 years? Or are they completely incompetent? But then it doesn't seem to work that well.
The latest here:
NextStep Robotics seeks FDA authorization to use its lower body exoskeleton for more than just exercise
- Founded by: Bradley Hennessie, Richard Macko, Larry Forrester, Anindo Roy
- Year founded: 2017
- Headquarters: Baltimore, MD
- Sector: Biotech
- Funding and valuation: $8 million raised at a $10 million valuation, according to the company
- Key ecosystem partners: TEDCO, Abell Foundation, University of Maryland, Baltimore
A Baltimore startup could help stroke survivors improve how they move, even months after rehab ends.
NextStep Robotics’ AMBLE device targets foot drop, a condition that limits someone’s ability to lift the front of the foot while walking. The assistive tech is gathering another FDA authorization, with affordability front of mind, according to CEO Bradley Hennessie.
“Our clinical trial results show that it has much more benefit than just being helpful during exercise.”
Bradley Hennessie, NextStep Robotics
“Most small community-based clinics can’t afford a $120,000 exoskeleton system,” Hennessie told Technical.ly.
Most rehabilitation happens in lower-budget clinics rather than resource-rich institutions, Hennessie said. AMBLE charges clinics a subscription fee for the device and software package, instead of an upfront fee, but costs can vary, Hennessie said.
The device is worn on the knee, paired with a sensor on the shoe that tracks a patient’s steps in real time. It helps lift the foot with robotic assistance, adjusting as the patient gets stronger.
AMBLE is currently FDA-cleared as an exercise device, which allows NextStep to sell it to clinics for use during gait therapy. But Hennessie said he hopes the next level of FDA clearance, called a De Novo submission, will expand its use.
The team completed its three-year, National Institutes of Health–funded clinical trials in 2024, after the onset of the COVID-19 pandemic delayed the study’s start. Conducted at the University of Maryland, Baltimore, the trials found that patients continued to improve in key walking measures for months after training ended, including follow-ups more than a year later.
Potential for spine, arm assistive tech
While AMBLE was initially developed to treat foot drop, the company sees broader potential for the technology.
Most recently, NextStep received approval from the Kennedy Krieger Institute to test the device with spinal cord injury patients. The team is planning to gather preliminary data from a small pool of patients before conducting a larger study, Hennessie said.
NextStep is also developing other devices.
The company is creating a standalone version of its shoe-based sensor that can track how someone walks without the exoskeleton, according to Hennessie. The sensor is designed to monitor changes in walking patterns and, over time, help identify patients at risk of falling.
NextStep is also developing an upper-extremity device, for the arm or hand, that uses the same “assist-as-needed” approach as AMBLE.
The company is finalizing its shoe sensor product. An initial prototype of its upper extremity device was developed and tested as a part of a Ph.D. project at the University of Maryland, Baltimore.
“We make sure that,” Hennessie said, “the user is making as much of the motion on their own [as possible].”
No comments:
Post a Comment